U.S. Department of Health and Human Services home page Health Resources and Services Administration home page U.S. Department of Health and Human Services home page Health Resources and Services Administration home page H I V/AIDS Bureau (H A B) home page Contact Us Search
skip header and navigation
U.S. Department of Health and Human Services Health Resources and Services AdministrationU.S. Department of Health and Human Services Health Resources and Services AdministrationH I V/AIDS Bureau (H A B)Contact UsSearch
three people in a meetingman sitting by the waterman talking on a telephonegirl sitting on the flooryoung couple
U.S. Department of Health and Human Services home page Health Resources and Services Administration home page U.S. Department of Health and Human Services home page Health Resources and Services Administration home page H I V/AIDS Bureau (H A B) home page Contact Us Search
About HIV/AIDS Bureau
Ryan White HIV/AIDS Program
Law & Policy
Programs
Special Initiative
Reports & Studies
Tools for Grantees
Data
News & Events
Education & Training
Publications
Links

 
Tools for Grantees: A Guide To Primary Care For
People With HIV/AIDS, 2004 edition


< Previous | Home | Next >
Introduction
    Editors
    Dedication
    Acknowledgements
    Contributing Authors
    Abbreviations
    Glossary of Antiretroviral Drugs

Introduction

Editors  TOP

John G. Bartlett, MD
Professor of Medicine
Chief, Division of Infectious Diseases
Director, AIDS Service
The Johns Hopkins University School of Medicine
Baltimore, Maryland

Laura W. Cheever, MD, ScM
Deputy Associate Administrator
Chief Medical Officer
HIV/AIDS Bureau
Health Resources and Services Administration
Rockville, Maryland

Michael P. Johnson, MD, MPH
Director, Office of Global AIDS
Office of Global Health Affairs, Office of the Secretary
Department of Health and Human Services
Washington, D.C.

Douglas S. Paauw, MD, FACP
Professor of Medicine
Rathmann Family Foundation Endowed Chair for Patient-Centered Clinical Education
University of Washington School of Medicine
Seattle, Washington


Dedication  TOP

A Guide to Primary Care of People with HIV/AIDS is dedicated to all the men and women working in the Ryan White CARE Act programs. Their commitment and dedication to serving people living with HIV and AIDS makes these programs possible.


Acknowledgements  TOP

Helen Schietinger managed the development and production of the guide.

Joan Holloway oversaw its conception and execution.

Cover design and layout was done by Laura Spofford.

Design and layout of the book was done by Patrice Lincoln.

Frances Porcher and Helen Schietinger copyedited the text, and Bill Todd created the index.


Contributing Authors  TOP

Bruce D. Agins, MD, MPH
Medical Director, New York State Department of Health AIDS Institute, New York, New York

Carla S. Alexander, MD
Assistant Professor of Medicine, Medical Director of Palliative Care, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland

John G. Bartlett, MD
Professor of Medicine Chief, Division of Infectious Diseases, Director, AIDS Service, The John Hopkins University School of Medicine, Baltimore, Maryland

Constance A. Benson, MD
Professor of Medicine, Division of Infectious Diseases, University of Colorado Health Sciences Center, Denver, Colorado

Kennita R. Carter, MD
Clinical Assistant Professor, Department of Hematology/Oncology, Veterans Administration Medical Center, Baltimore, Maryland

Gloria A. Casale, MD, MSPH
Adjunct Professor, University of St. Francis, Adjunct Professor, University of New Mexico School of Medicine, Albuquerque, New Mexico

Laura W. Cheever, MD, ScM
Deputy Associate Administrator, Chief Medical Officer, HIV/AIDS Bureau Health Resources and Services Administration, Rockville, Maryland

Jonathan Allen Cohn, MD, MS, FACP
Associate Professor of Medicine, Wayne State University School of Medicine, Detroit, Michigan

Niccolo D. Della Penna, MD
Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland

Henry Francis, MD
Director, Center on AIDS and Other Medical Consequences of Drug Abuse, National Institute on Drug Abuse, National Institutes of Health, Rockville, Maryland

Linda Frank, PhD, MSN, ACRN
Assistant Professor, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania

Michael P. Johnson, MD, MPH
Director, Office of Global AIDS, Office of Global Health Affairs, Office of the Secretary, Department of Health and Human Services, Washington, DC

John McNeil, MD
Chief, Infectious Diseases, Howard University Hospital, Washington, DC

José Rafael Morales, MD, FACOG
Associate Director for Clinical Affairs, Division of Community Based Programs, HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, Maryland

Tara Evans Nysoe, MD
Department of Medicine, University of Washington School of Medicine, Seattle, Washington

Douglas S. Paauw, MD, FACP
Professor of Medicine, Rathmann Family Foundation Endowed Chair for Patient-Centered Clinical Education, Division of General Internal Medicine, University of Washington, School of Medicine, Seattle, Washington

María del Carmen Ríos, MD, MPH
Acting Chief, Northeastern Regional Branch, Division of Community Based Programs, HIV/AIDS Bureau, Health Resources and Services Administration, Rockville, Maryland

John V. L. Sheffield, MD
Associate Professor of Medicine, Division of General Internal Medicine, University of Washington, School of Medicine, Seattle, Washington

Renslow Sherer, MD
Director, Coordinated HIV Services, The CORE Center Cook County Hospital, Chicago, Illinois

David H. Spach, MD
Associate Professor of Medicine, Division of Infectious Diseases, Department of Medicine, University of Washington Medical Center, Seattle, Washington

Caroline J. Teter, PA-C, MPH
Project Coordinator, AIDS Education and Training Center National Resource Center, Cook County Hospital, Chicago, Illinois

Glenn J. Treisman, MD, PhD
Associate Professor, Department of Psychiatry, The Johns Hopkins University School of Medicine, Baltimore, Maryland


Abbreviations  TOP

ALT: alanine aminotransferase

anti-HBc: hepatitis B core antibody

ART: antiretroviral therapy, highly active antiretroviral therapy

bid: twice a day

c/mL: copies of virus per mL

DSP: distal symmetrical polyneuropathy

DRESS: drug rash with eosinophilia and systemic symptoms

FTA-ABS: fluorescent treponemal antibody absorption test for syphilis

HAART: highly active antiretroviral therapy (see ART)

INH: isoniazid

HCV: hepatitis C virus

IVIG: intravenous immune globulin

LDL: low-density lipoprotein

LFT: liver function test

MAC: Mycobacterium avium complex

nPEP: nonoccupational postexposure prophylaxis

NRTI: nucleoside reverse transcriptase inhibitor, nucleoside

NNRTI: non-nucleoside reverse transcriptase inhibitor

OD: opportunistic disease

OI: opportunistic infection

po: per os, by mouth

PI: protease inhibitor

PPD: purified protein derivative of tuberculin

qd: every day

qhs: every night

qam: every morning

RPR: rapid plasma regain test for syphilis

SSRI: selective serotonin reuptake inhibitor

STD: sexually transmitted disease

STI: sexually transmitted infection

TB: tuberculosis

VDRL: Venereal Disease Research Laboratory serologic test for syphilis

VL: viral load


Glossary of Antiretroviral Drugs  TOP

Generic name Abbreviation Trade name Class
abacavir ABC Ziagen nucleoside
amprenavir APV Agenerase PI
atazanavir ATV Reyataz PI
delavirdine DLV Rescriptor NNRTI
didanosine ddI Videx nucleoside
efavirenz EFV Sustiva NNRTI
emtricitabine FTC Emtriva nucleoside
enfuvirtide T-20 Fuzeon fusion inhibitor
fosamprenavir FPV Lexiva PI
indinavir IDV Crixivan PI
lamivudine 3TC Epivir nucleoside
lopinavir + ritonavir LPV/r Kaletra PIs
nelfinavir NFV Viracept PI
nevirapine NVP Viramine NNRTI
ritonavir RTV Norvir PI
saquinavir SQV soft gel cap Fortovase PI
saquinavir SQV hard gel cap Invirase PI
stavudine d4T Zerit nucleoside
tenofovir TDF Viread nucleotide
zalcitabine ddC Hivid nucleoside
zidovudine AZT, ZDV Retrovir nucleoside
zidovudine + lamivudine AZT + 3TC Combivir nucleosides
zidovudine + lamivudine + abacavir AZT + 3TC + ABC Trizivir nucleosides

PI: Protease Inhibitor
NNRTI: non-nucleoside reverse transcriptase inhibitor
nucleoside: nucleoside reverse transcriptase inhibitor (NRTI)

 


Top | Home | HRSA | HHS | Disclaimer | Accessibility | Privacy
| Download Adobe Reader| | Freedom of Information Act